UBS AM
TWST icon

UBS AM’s Twist Bioscience TWST Stock Holding History

UBS AM’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58M Sell
563,782
-260,194
-32% -$16.9M 0.01% 618
2026
Q1 		$39.2M Sell
823,976
-349,124
-30% -$15.7M 0.01% 680
2025
Q4 		$37.2M Buy
1,173,100
+49,403
+4% +$1.54M 0.01% 679
2025
Q3 		$31.6M Sell
1,123,697
-95,691
-8% -$2.9M 0.01% 689
2025
Q2 		$44.9M Sell
1,219,388
-1,222,874
-50% -$42.3M 0.01% 729
2025
Q1 		$95.9M Buy
2,442,262
+1,588,587
+186% +$71.5M 0.02% 547
2024
Q4 		$39.7M Sell
853,675
-26,524
-3% -$1.2M 0.01% 718
2024
Q3 		$39.8M Sell
880,199
-81,038
-8% -$3.86M 0.01% 725
2024
Q2 		$47.4M Buy
961,237
+869,362
+946% +$35.5M 0.01% 626
2024
Q1 		$3.15M Hold
91,875
– – ﹤0.01% 1465
2023
Q4 		$3.39M Buy
91,875
+11,040
+14% +$255K ﹤0.01% 1439
2023
Q3 		$1.64M Buy
80,835
+32,287
+67% +$709K ﹤0.01% 1723
2023
Q2 		$732K Hold
48,548
– – ﹤0.01% 2148
2023
Q1 		$732K Sell
48,548
-8,347
-15% -$184K ﹤0.01% 2148
2022
Q4 		$1.35M Buy
56,895
+2,601
+5% +$75.4K ﹤0.01% 1707
2022
Q3 		$1.91M Buy
54,294
+2,121
+4% +$90.1K ﹤0.01% 1624
2022
Q2 		$1.82M Sell
52,173
-2,704
-5% -$95.8K ﹤0.01% 1660
2022
Q1 		$2.71M Buy
54,877
+4,026
+8% +$223K ﹤0.01% 1632
2021
Q4 		$3.94M Buy
50,851
+8,482
+20% +$871K ﹤0.01% 1528
2021
Q3 		$4.53M Buy
42,369
+1,162
+3% +$133K ﹤0.01% 1390
2021
Q2 		$5.49M Buy
41,207
+9,841
+31% +$1.14M ﹤0.01% 1324
2021
Q1 		$3.88M Sell
31,366
-52,373
-63% -$7.95M ﹤0.01% 1455
2020
Q4 		$11.8M Sell
83,739
-55,395
-40% -$6.15M 0.01% 999
2020
Q3 		$10.6M Sell
139,134
-46,377
-25% -$2.89M 0.01% 930
2020
Q2 		$8.4M Buy
185,511
+167,443
+927% +$6.01M 0.01% 952
2020
Q1 		$553K Buy
+18,068
New +$486K ﹤0.01% 1941

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

UBS AM's TWST Position: Q2 2026 in Review

UBS AM reduced its Twist Bioscience (TWST) stake by 32% in Q2 2026, selling an estimated $16.9M and leaving 563,782 shares worth $58M. The position accounts for 0.01% of the portfolio, ranked #618.

UBS AM first reported a position in TWST in Q1 2020 and has held it in 26 quarters since. The position peaked at $95.9M in Q1 2025. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • UBS AM held 563,782 shares of Twist Bioscience worth $58M as of Q2 2026.
  • UBS AM sold 260,194 Twist Bioscience shares in Q2 2026, an estimated $16.9M.
  • Twist Bioscience made up 0.01% of UBS AM's portfolio in Q2 2026, its #618 holding.
  • UBS AM first reported a position in Twist Bioscience in Q1 2020 and has held it in 26 quarters since.
  • UBS AM's Twist Bioscience position peaked at $95.9M in Q1 2025.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.